[HTML][HTML] Endovascular treatment for acute ischemic stroke
A Ciccone, L Valvassori, M Nichelatti… - … England Journal of …, 2013 - Mass Medical Soc
Background In patients with ischemic stroke, endovascular treatment results in a higher rate
of recanalization of the affected cerebral artery than systemic intravenous thrombolytic …
of recanalization of the affected cerebral artery than systemic intravenous thrombolytic …
Recommendations for imaging of acute ischemic stroke: a scientific statement from the American Heart Association
RE Latchaw, MJ Alberts, MH Lev, JJ Connors… - Stroke, 2009 - Am Heart Assoc
Worldwide, stroke is a leading cause of death and disability. Recombinant tissue
plasminogen activator (rtPA) was approved a decade ago for the treatment of acute ischemic …
plasminogen activator (rtPA) was approved a decade ago for the treatment of acute ischemic …
Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American …
Background and Purpose—The authors present an overview of the current evidence and
management recommendations for evaluation and treatment of adults with acute ischemic …
management recommendations for evaluation and treatment of adults with acute ischemic …
Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial
A Furlan, R Higashida, L Wechsler, M Gent, H Rowley… - Jama, 1999 - jamanetwork.com
ContextIntravenous tissue-type plasminogen activator can be beneficial to some patients
when given within 3 hours of stroke onset, but many patients present later after stroke onset …
when given within 3 hours of stroke onset, but many patients present later after stroke onset …
Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke
RT Higashida, AJ Furlan - stroke, 2003 - Am Heart Assoc
Background and Purpose—The National Institutes of Health (NIH) estimates that stroke
costs now exceed $45 billion per year. Stroke is the third leading cause of death and one of …
costs now exceed $45 billion per year. Stroke is the third leading cause of death and one of …
Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke: a statement for …
Guidelines for Thrombolytic Therapy for Acute Stroke: A Supplement to the Guidelines for the
Management of Patients With Acute Ischemic Stroke | Circulation Science Volunteer Warning …
Management of Patients With Acute Ischemic Stroke | Circulation Science Volunteer Warning …
CT and MRI early vessel signs reflect clot composition in acute stroke
DS Liebeskind, N Sanossian, WH Yong, S Starkman… - Stroke, 2011 - Am Heart Assoc
Background and Purpose—The purpose of this study was to provide the first correlative
study of the hyperdense middle cerebral artery sign (HMCAS) and gradient-echo MRI …
study of the hyperdense middle cerebral artery sign (HMCAS) and gradient-echo MRI …
Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial
CA Lewandowski, M Frankel, TA Tomsick, J Broderick… - Stroke, 1999 - Am Heart Assoc
Background and Purpose—The purpose of this study was to test the feasibility, efficacy, and
safety of combined intravenous (IV) and local intra-arterial (IA) recombinant tissue …
safety of combined intravenous (IV) and local intra-arterial (IA) recombinant tissue …
Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention …
A Ogawa, E Mori, K Minematsu, W Taki, A Takahashi… - Stroke, 2007 - Am Heart Assoc
Background and Purpose—The Middle Cerebral Artery Embolism Local Fibrinolytic
Intervention Trial (MELT) Japan was organized to determine the safety and clinical efficacy …
Intervention Trial (MELT) Japan was organized to determine the safety and clinical efficacy …
The interventional management of stroke (IMS) II study
Ims Ii Trial Investigators - Stroke, 2007 - Am Heart Assoc
Background and Purpose—The purpose of this study was to further investigate the feasibility
and safety of a combined intravenous and intra-arterial approach to recanalization for …
and safety of a combined intravenous and intra-arterial approach to recanalization for …